Issued Patents All Time
Showing 1–9 of 9 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12011441 | Pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease | Christoph Matthias SCHUMMER | 2024-06-18 |
| 11413285 | PDE III inhibitors for treatment of asymptomatic heart failure | Juergen Daemmgen, Rainer Kleemann, Christian Troetschel, Andrea Vollmar | 2022-08-16 |
| 10537570 | Use of pimobendan for the reduction of heart size and/or the delay of onset of clinical symptoms in patients with asymptomatic heart failure due to mitral valve disease | Christoph Matthias SCHUMMER | 2020-01-21 |
| 10537588 | Use of pimobendan for the reduction of heart size in mammals suffering from heart failure | Juergen Daemmgen, Rainer Kleemann | 2020-01-21 |
| 10117869 | PDE III inhibitors for treatment of asymptomatic heart failure | Juergen Daemmgen, Rainer Kleemann, Christian Troetschel, Andrea Vollmar | 2018-11-06 |
| 9889148 | Use of pimobendan for the reduction of heart size in mammals suffering from heart failure | Juergen Daemmgen, Rainer Kleemann | 2018-02-13 |
| 9463199 | Use of PDE III inhibitors for the reduction of heart size in mammals suffering from heart failure | Juergen Daemmgen, Rainer Kleemann | 2016-10-11 |
| 8980894 | Use of PDE III inhibitors for the treatment of asymptomatic (occult) heart failure | Juergen Daemmgen, Rainer Kleemann, Christian Troetschel, Andrea Vollmar | 2015-03-17 |
| 8664252 | Phosphodiesterase type III (PDE III) inhibitors or CA2+-sensitizing agents for the treatment of hypertrophic cardiomyopathy | Juergen Daemmgen | 2014-03-04 |